Vaxcyte (PCVX) Amortizatization of Intangibles (2021 - 2026)
Vaxcyte (PCVX) posted quarterly Amortizatization of Intangibles of $3.1 million for Q1 2026, down 36.66% year-over-year from $4.9 million in Q1 2025, and up 12.59% quarter-over-quarter from $2.8 million in Q4 2025.
Vaxcyte (PCVX) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Vaxcyte (PCVX) has reported Amortizatization of Intangibles for 6 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 36.66% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $12.6 million (down 61.28% YoY), while the FY2025 annual figure was $14.4 million, down 62.71% from the prior year.
- Amortizatization of Intangibles grew to $3.1 million in Q1 2026 per PCVX's latest filing, from $2.8 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $14.6 million in Q3 2023 and bottomed at -$321000.0 in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $5.4 million across 5 years, with a median of $4.5 million in 2025.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles tumbled 112.58% — and 2023, when it surged 8268.28%.
- Vaxcyte's Amortizatization of Intangibles stood at $1.2 million in 2022, then soared by 101.62% to $2.4 million in 2023, then jumped by 392.87% to $11.7 million in 2024, then slumped by 76.33% to $2.8 million in 2025, then gained by 12.59% to $3.1 million in 2026.
- Business Quant data shows PCVX's Amortizatization of Intangibles at $3.1 million in Q1 2026, $2.8 million in Q4 2025, and $2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.33 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 678,000.00 |
| 10 | Vaxcyte | 8.41 Bn | 8.41 Bn | - | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Mn |
| Jun 30, 2026 | 1.18 Mn |
| Mar 31, 2026 | 3.11 Mn |
| Mar 31, 2026 | 3.11 Mn |
| Dec 31, 2025 | 2.76 Mn |
| Dec 31, 2025 | 2.76 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Jun 30, 2025 | 4.49 Mn |
| Jun 30, 2025 | 4.49 Mn |
| Mar 31, 2025 | 4.91 Mn |
| Mar 31, 2025 | 4.91 Mn |
| Dec 31, 2024 | 11.68 Mn |
| Dec 31, 2024 | 11.68 Mn |
| Sep 30, 2024 | 6.10 Mn |
| Sep 30, 2024 | 6.10 Mn |
| Jun 30, 2024 | 9.93 Mn |
| Jun 30, 2024 | 9.93 Mn |
| Mar 31, 2024 | 10.99 Mn |
| Mar 31, 2024 | 10.99 Mn |